Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Influenza Vaccines"" wg kryterium: Temat


Starter badań:

Tytuł:
Knowledge, attitudes, beliefs and barriers of healthcare professionals and adults ≥ 65 years about vaccine-preventable diseases in Spain: the ADult Vaccination drIverS and barriErs (ADVISE) study.
Autorzy:
Redondo Margüello E; Centro de Vacunación y Salud Internacional, Organismo Autónomo Madrid Salud, Madrid, Spain.
Trilla A; Servicio de Medicina Preventiva del Hospital Clinic de Barcelona, Barcelona, Spain.
Munguira ILB; Medical Affairs, MSD, Madrid, Spain.
López-Herce AJ; Medical Affairs, MSD, Madrid, Spain.
Cotarelo Suárez M; Medical Affairs, MSD, Madrid, Spain.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 2025007. Date of Electronic Publication: 2022 Feb 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/prevention & control
Influenza Vaccines*
Influenza, Human*/prevention & control
Vaccine-Preventable Diseases*
Adult ; Aged ; Cross-Sectional Studies ; Health Knowledge, Attitudes, Practice ; Humans ; Pandemics ; Pneumococcal Vaccines ; Spain ; Surveys and Questionnaires ; Vaccination
Czasopismo naukowe
Tytuł:
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU).
Autorzy:
Severance R; Synexus Clinical Research, Chandler, AZ, USA.
Schwartz H; Research Centers of America, Hollywood, FL, USA.
Dagan R; Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
Connor L; Merck & Co., Inc., Kenilworth, NJ, USA.
Li J; Merck & Co., Inc., Kenilworth, NJ, USA.
Pedley A; Merck & Co., Inc., Kenilworth, NJ, USA.
Hartzel J; Merck & Co., Inc., Kenilworth, NJ, USA.
Sterling TM; Merck & Co., Inc., Kenilworth, NJ, USA.
Nolan KM; Merck & Co., Inc., Kenilworth, NJ, USA.
Tamms GM; Merck & Co., Inc., Kenilworth, NJ, USA.
Musey LK; Merck & Co., Inc., Kenilworth, NJ, USA.
Buchwald UK; Merck & Co., Inc., Kenilworth, NJ, USA.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1-14. Date of Electronic Publication: 2021 Nov 02.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms:
Immunogenicity, Vaccine*
Influenza Vaccines*/administration & dosage
Influenza Vaccines*/adverse effects
Pneumococcal Vaccines*/administration & dosage
Pneumococcal Vaccines*/adverse effects
Aged ; Antibodies, Bacterial ; Humans ; Influenza, Human/prevention & control ; Middle Aged ; Pneumococcal Infections/prevention & control ; Streptococcus pneumoniae/immunology ; Vaccines, Combined/adverse effects ; Vaccines, Conjugate/administration & dosage ; Vaccines, Conjugate/adverse effects
Czasopismo naukowe
Tytuł:
Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up system.
Autorzy:
Betancourt-Cravioto M; Sociedad Mexicana de Salud Pública, CDMX, Mexico.
Cervantes-Powell P; Medical Department, Sanofi Pasteur, CDMX, México.
Tapia-Conyer R; Family Medicine, School of Medicine. National Autonomous University of Mexico, Mexico City, Mexico.
Ledlie S; Epidemiology and Benefit-Risk Department, Sanofi Pasteur, Toronto, Ontario, Canada.
Gandhi-Banga S; Epidemiology and Benefit-Risk Department, Sanofi Pasteur, Toronto, Ontario, Canada.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1935170. Date of Electronic Publication: 2021 Aug 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*/adverse effects
Influenza, Human*/prevention & control
Adult ; Child ; Follow-Up Studies ; Humans ; Influenza A Virus, H3N2 Subtype ; Marketing ; Mexico/epidemiology ; Vaccines, Combined ; Vaccines, Inactivated/adverse effects
Czasopismo naukowe
Tytuł:
Influenza vaccination in coronavirus times: Primary Care professionals' intention to get vaccinated in Central Catalonia (VAGCOVID). A cross sectional study.
Autorzy:
Muñoz-Miralles R; Centre d'Atenció Primària Plaça Catalunya, SAP Bages-Berguedà-Solsonès, Gerència Territorial Catalunya Central Institut Català de la Salut, Manresa, Spain.
Bonet-Esteve A; Unitat de Farmàcia, GerènciaTerritorial Catalunya Central Institut Català de la Salut, SantFruitós de Bages, Spain.; Health Promotion in Rural Areas Research Group, Gerència Territorial de la Catalunya Central, Institut Català de la Salut, SantFruitós de Bages, Spain.
Rufas-Cebollero A; Centre d'Atenció Primària Manlleu, SAP Osona, Gerència Territorial Catalunya Central, Institut Català de la Salut, Manlleu, Spain.
Fuster-Casanovas A; la Recerca de la Catalunya Central, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i GurinaUnitat de Suport a , Sant Fruitós de Bages, Spain.
Pelegrin-Cruz X; Departament de Matemàtiques, Universitat Autònoma de Barcelona, Barcelona, Spain.
Vidal-Alaball J; Health Promotion in Rural Areas Research Group, Gerència Territorial de la Catalunya Central, Institut Català de la Salut, SantFruitós de Bages, Spain.; la Recerca de la Catalunya Central, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i GurinaUnitat de Suport a , Sant Fruitós de Bages, Spain.; Faculty of Medicine, University of Vic - Central University of Catalonia, Vic, Spain.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (5), pp. 2067442. Date of Electronic Publication: 2022 Jul 01.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Cross-Sectional Studies ; Humans ; Intention ; Primary Health Care ; SARS-CoV-2 ; Spain ; Vaccination
Czasopismo naukowe
Tytuł:
The influenza universe in an mRNA vaccine.
Autorzy:
Kelvin AA; Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Saskatchewan, Canada.; Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Falzarano D; Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Saskatchewan, Canada.; Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2022 Nov 25; Vol. 378 (6622), pp. 827-828. Date of Electronic Publication: 2022 Nov 24.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Influenza B virus*/immunology
Influenza Vaccines*/genetics
Influenza Vaccines*/immunology
Influenza, Human*/prevention & control
mRNA Vaccines*/genetics
mRNA Vaccines*/immunology
Vaccines, Synthetic*/genetics
Vaccines, Synthetic*/immunology
Influenzavirus A*/immunology
Animals ; Mice ; Ferrets
Czasopismo naukowe
Tytuł:
Knowledge, attitudes, and practices regarding seasonal influenza vaccination during pregnancy in Costa Rica: A mixed-methods study.
Autorzy:
Madewell ZJ; Centro de Estudios en Salud, Universidad del Valle de Guatemala, Guatemala City, Guatemala. Electronic address: .
Chacón-Fuentes R; Centro de Estudios en Salud, Universidad del Valle de Guatemala, Guatemala City, Guatemala.
Badilla-Vargas X; Caja Costarricense del Seguro Social, San José, Costa Rica.
Ramirez C; Caja Costarricense del Seguro Social, San José, Costa Rica.
Ortiz MR; Centro de Estudios en Salud, Universidad del Valle de Guatemala, Guatemala City, Guatemala.
Alvis-Estrada JP; Centro de Estudios en Salud, Universidad del Valle de Guatemala, Guatemala City, Guatemala.
Jara J; Centro de Estudios en Salud, Universidad del Valle de Guatemala, Guatemala City, Guatemala.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2022 Nov 15; Vol. 40 (48), pp. 6931-6938. Date of Electronic Publication: 2022 Oct 21.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/prevention & control
Pregnancy Complications, Infectious*/prevention & control
Influenza Vaccines*
Child ; Female ; Humans ; Pregnancy ; Costa Rica/epidemiology ; Health Knowledge, Attitudes, Practice ; Cross-Sectional Studies ; Seasons
Czasopismo naukowe
Tytuł:
Outcomes of COVID-19 Infection in People Previously Vaccinated Against Influenza: Population-Based Cohort Study Using Primary Health Care Electronic Records.
Autorzy:
Giner-Soriano M; Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain.
de Dios V; Department of Clinical Pharmacology, Medicines Area, Hospital Clinic of Barcelona, Barcelona, Spain.
Ouchi D; Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain.
Vilaplana-Carnerero C; Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain.
Monteagudo M; Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain.
Morros R; Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain.; Plataforma Spanish Clinical Research Network, Unidad de Investigación Clínica, Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.; Institut Català de la Salut, Barcelona, Spain.
Pokaż więcej
Źródło:
JMIR public health and surveillance [JMIR Public Health Surveill] 2022 Nov 11; Vol. 8 (11), pp. e36712. Date of Electronic Publication: 2022 Nov 11.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
COVID-19*/epidemiology
COVID-19*/prevention & control
Humans ; Pandemics/prevention & control ; SARS-CoV-2 ; Cohort Studies ; Primary Health Care ; Electronics
Czasopismo naukowe
Tytuł:
High-dose influenza vaccines for the prevention of hospitalization due to cardiovascular events in older adults in the nursing home: Post-hoc analysis of a cluster-randomized trial.
Autorzy:
Saade EA; University Hospitals Cleveland Medical Center, Cleveland, OH, United States; Case Western Reserve University, Cleveland, OH, United States. Electronic address: .
Abul Y; School of Public Health, Brown University, Providence, RI, United States; Center on Innovation in Long-Term Services and Supports, Veterans Administration Medical Center, Providence, RI, United States.
McConeghy K; School of Public Health, Brown University, Providence, RI, United States; Center on Innovation in Long-Term Services and Supports, Veterans Administration Medical Center, Providence, RI, United States.
Edward Davidson H; Insight Therapeutics, LLC, Norfolk, VA, United States.
Han L; Insight Therapeutics, LLC, Norfolk, VA, United States.
Joyce N; School of Public Health, Brown University, Providence, RI, United States.
Canaday DH; Case Western Reserve University, Cleveland, OH, United States; Veterans Administration Medical Center, Cleveland, OH, United States.
Hsueh L; Warren Alpert Medical School of Brown University, Providence, RI, United States.
Bosco E; School of Public Health, Brown University, Providence, RI, United States.
Gravenstein S; School of Public Health, Brown University, Providence, RI, United States; Center on Innovation in Long-Term Services and Supports, Veterans Administration Medical Center, Providence, RI, United States; Warren Alpert Medical School of Brown University, Providence, RI, United States. Electronic address: stefan_.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2022 Nov 08; Vol. 40 (47), pp. 6700-6705. Date of Electronic Publication: 2022 Oct 14.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Influenza Vaccines*
Influenza, Human*
Cardiovascular Diseases*
Aged ; Humans ; United States ; Medicare ; Hospitalization ; Nursing Homes
Czasopismo naukowe
Tytuł:
Domination of influenza vaccine virus strains in Hong Kong, 2021.
Autorzy:
Mak GCK; Microbiology Division, Public Health Laboratory Services Branch, Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region, China.
Lau SSY; Microbiology Division, Public Health Laboratory Services Branch, Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region, China.
Lam ETK; Microbiology Division, Public Health Laboratory Services Branch, Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region, China.
Ng KHL; Microbiology Division, Public Health Laboratory Services Branch, Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region, China.
Chan RCW; Microbiology Division, Public Health Laboratory Services Branch, Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region, China.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2022 Nov; Vol. 16 (6), pp. 1191-1193. Date of Electronic Publication: 2022 Jun 01.
Typ publikacji:
Letter
MeSH Terms:
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Orthomyxoviridae*
Hong Kong/epidemiology ; Humans ; Vaccines, Attenuated
Opinia redakcyjna
Tytuł:
Two years of on-site influenza vaccination strategy in an Italian university hospital: main results and lessons learned.
Autorzy:
Bianchi FP; Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy.
Tafuri S; Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy.
Spinelli G; Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy.
Carlucci M; Hospital Direction, Bari Policlinico General Hospital, Bari, Italy.
Migliore G; Hospital Direction, Bari Policlinico General Hospital, Bari, Italy.
Calabrese G; Hospital Direction, Bari Policlinico General Hospital, Bari, Italy.
Daleno A; Hospital Direction, Bari Policlinico General Hospital, Bari, Italy.
Melpignano L; Hospital Direction, Bari Policlinico General Hospital, Bari, Italy.
Vimercati L; Interdisciplinary Department of Medicine, University of Bari, Bari, Italy.; Unit of Occupational Medicine, University Hospital of Bari, Bari, Italy.
Stefanizzi P; Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1993039. Date of Electronic Publication: 2021 Nov 04.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*
Influenza, Human*/prevention & control
Attitude of Health Personnel ; Health Personnel ; Hospitals, University ; Humans ; Male ; Surveys and Questionnaires ; Vaccination
Czasopismo naukowe
Tytuł:
Determinants of healthcare workers perceptions, acceptance and choice of COVID-19 vaccines: a cross-sectional study from the United Arab Emirates.
Autorzy:
Saddik B; Department of Family and Community Medicine and Behavioural Sciences, College of Medicine, University of Sharjah, Sharjah, UAE.; Oncology Unit, Sharjah Institute for Medical and Health Sciences Research, University of Sharjah, Sharjah, UAE.
Al-Bluwi N; Oncology Unit, Sharjah Institute for Medical and Health Sciences Research, University of Sharjah, Sharjah, UAE.
Shukla A; Oncology Unit, Sharjah Institute for Medical and Health Sciences Research, University of Sharjah, Sharjah, UAE.
Barqawi H; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, UAE.
Alsayed HAH; Pharmacy Department, Dubai Health Authority, Dubai, United Arab Emirates.
Sharif-Askari NS; Oncology Unit, Sharjah Institute for Medical and Health Sciences Research, University of Sharjah, Sharjah, UAE.
Temsah MH; Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia.; Prince Abdullah Ben Khaled Celiac Disease Research Chair, Department of Pediatrics, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia.
Bendardaf R; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, UAE.; University Hospital Sharjah, Sharjah, UAE.
Hamid Q; Oncology Unit, Sharjah Institute for Medical and Health Sciences Research, University of Sharjah, Sharjah, UAE.; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, UAE.
Halwani R; Oncology Unit, Sharjah Institute for Medical and Health Sciences Research, University of Sharjah, Sharjah, UAE.; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, UAE.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1-9. Date of Electronic Publication: 2021 Nov 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/prevention & control
Influenza Vaccines*/adverse effects
COVID-19 Vaccines ; Cross-Sectional Studies ; Health Personnel ; Humans ; Male ; United Arab Emirates/epidemiology ; Vaccination
Czasopismo naukowe
Tytuł:
mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic.
Autorzy:
Chen P; Zhujiang Hospital, Southern Medical University/The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Shi X; Zhujiang Hospital, Southern Medical University/The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
He W; Nanfang Hospital, Southern Medical University/The First School of Clinical Medicine, Southern Medical University, No, Guangzhou, Guangdong, People's Republic of China.
Zhong G; School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Tang Y; Zhujiang Hospital, Southern Medical University/The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Wang H; Department of Cardiology, Heart Center, People's Hospital of Guangning County, Zhaoqing City, Guangdong, People's Republic of China.
Zhang P; Department of Cardiology, Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 2040330. Date of Electronic Publication: 2022 Mar 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/prevention & control
Influenza Vaccines*
Influenza, Human*/prevention & control
COVID-19 Vaccines ; Humans ; Pandemics/prevention & control ; Vaccines, Synthetic ; mRNA Vaccines
Czasopismo naukowe
Tytuł:
Assessment of the relationship between COVID-19 risk perception and vaccine acceptance: a cross-sectional study in Jordan.
Autorzy:
Nusair MB; Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.
Arabyat R; Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.
Khasawneh R; Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Al-Azzam S; Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Nusir AT; Faculty of Arts, Yarmouk University, Irbid, Jordan.
Alhayek MY; Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 2017734. Date of Electronic Publication: 2022 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Influenza Vaccines*
Influenza, Human*/prevention & control
Adolescent ; Adult ; Aged ; COVID-19 Vaccines ; Child ; Cross-Sectional Studies ; Female ; Humans ; Jordan/epidemiology ; Male ; Patient Acceptance of Health Care ; Perception ; Young Adult
Czasopismo naukowe
Tytuł:
Systemic sclerosis and vaccinations: a three-year register-based cohort study about vaccination rate and uptake from Liguria referral center, northwest Italy.
Autorzy:
Murdaca G; Departments of Internal Medicine, University of Genova, Genova, Italy.
Noberasco G; Department of Health Sciences, Vaccines and Clinical Trials Unit, University of Genova, Genova, Italy.
Olobardi D; Department of Health Sciences, Vaccines and Clinical Trials Unit, University of Genova, Genova, Italy.
Ogliastro M; Department of Health Sciences, Vaccines and Clinical Trials Unit, University of Genova, Genova, Italy.
Sibilio R; Department of Health Sciences, Vaccines and Clinical Trials Unit, University of Genova, Genova, Italy.
Sambuceti G; Departments of Internal Medicine, University of Genova, Genova, Italy.
Balzano R; Departments of Internal Medicine, University of Genova, Genova, Italy.
Sticchi L; Department of Health Sciences, Vaccines and Clinical Trials Unit, University of Genova, Genova, Italy.; Hygiene Unit, 'Ospedale Policlinico San Martino IRCCS', Genova, Italy.
Icardi G; Department of Health Sciences, Vaccines and Clinical Trials Unit, University of Genova, Genova, Italy.; Hygiene Unit, 'Ospedale Policlinico San Martino IRCCS', Genova, Italy.
Orsi A; Department of Health Sciences, Vaccines and Clinical Trials Unit, University of Genova, Genova, Italy.; Hygiene Unit, 'Ospedale Policlinico San Martino IRCCS', Genova, Italy.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 2025732. Date of Electronic Publication: 2022 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Scleroderma, Systemic*
Aged ; Cohort Studies ; Humans ; Pneumococcal Vaccines ; Quality of Life ; Referral and Consultation ; Streptococcus pneumoniae ; Vaccination
Czasopismo naukowe
Tytuł:
Experience and attitudes on vaccinations recommended during pregnancy: survey on an Italian sample of women and consultant gynecologists.
Autorzy:
Scatigna M; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Appetiti A; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Pasanisi M; Department of Prevention, Local Health Authority No. 1 (ASL 1), Abruzzo, Italy.
D'Eugenio S; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Fabiani L; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Giuliani AR; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1-8. Date of Electronic Publication: 2021 May 06.
Typ publikacji:
Journal Article
MeSH Terms:
Diphtheria*/prevention & control
Diphtheria-Tetanus-acellular Pertussis Vaccines*
Influenza Vaccines*
Influenza, Human*/prevention & control
Tetanus*/prevention & control
Whooping Cough*/prevention & control
Attitude ; Consultants ; Cross-Sectional Studies ; Female ; Humans ; Infant, Newborn ; Male ; Pertussis Vaccine ; Pregnancy ; Surveys and Questionnaires ; Vaccination
Czasopismo naukowe
Tytuł:
How has COVID-19 pandemic changed flu vaccination attitudes among an Italian cancer center healthcare workers?
Autorzy:
Bertoni L; Healthcare Administration, IRCCS-Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori'- Irst, Meldola, Italy.
Roncadori A; Outcome Research, Healthcare Administration, IRCCS-Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori'- Irst, Meldola, Italy.
Gentili N; Outcome Research, Healthcare Administration, IRCCS-Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori'- Irst, Meldola, Italy.
Danesi V; Outcome Research, Healthcare Administration, IRCCS-Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori'- Irst, Meldola, Italy.
Massa I; Outcome Research, Healthcare Administration, IRCCS-Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori'- Irst, Meldola, Italy.
Nanni O; Unit of Biostatistics and Clinical Trials, IRCCS-Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori'- Irst, Meldola, Italy.
Altini M; Healthcare Administration, Azienda Unità Sanitaria Locale della Romagna, Ravenna, Italy.
Gabutti G; Department of Medical Sciences, Università di Ferrara, Ferrara, Italy.
Montella MT; Healthcare Administration, IRCCS-Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori'- Irst, Meldola, Italy.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1978795. Date of Electronic Publication: 2021 Oct 06.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Neoplasms*/epidemiology
Attitude ; Attitude of Health Personnel ; Female ; Health Personnel ; Humans ; Male ; Pandemics/prevention & control ; Retrospective Studies ; SARS-CoV-2 ; Seasons ; Surveys and Questionnaires ; Vaccination
Czasopismo naukowe
Tytuł:
Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study.
Autorzy:
Basu I; Department of Medicine, Popular Hospital, Varanasi, Uttar Pradesh, India.
Agarwal M; Department of Medicine, Medilink Hospital Research Centre, Ahmedabad, Gujrat, India.
Shah V; Department of Medicine, Panchshil Hospital, Ahmedabad, Gujarat, India.
Shukla V; Department of Ear, Nose and Throat, Ajanta Research Centre, Lucknow, Uttar Pradesh, India.
Naik S; Department of Medicine, Rajiv Gandhi Institute of Medical Sciences, Adilabad, Andhra Pradesh, India.
Supe PD; Department of Medicine, Supe Heart and Diabetes Hospital and Research Center, Nasik, Maharashtra, India.
Srivastava MK; Department of Medicine, OM Research Centre, Varanasi, Uttar Pradesh, India.
Giriraja KV; Department of General Medicine, Sapthagiri Institute of Medical Science & Research Centre, Bangalore, Karnataka, India.
Pinjar P; Department of General Medicine, S.S Institute of Medical Sciences and Research Center, Davangere, Karnataka, India.
Mishra PK; Department of General Medicine, Yashoda Hospital, Secunderabad, Andhra Pradesh, India.
Joshi S; Department of Medicine, Sahyadri Hospital, Pune, Maharashtra, India.
Vijayakumar R; Department of General Medicine, Krishna Rajendra Hospital, Mysuru, Karnataka, India.
van de Witte S; Established Pharmaceuticals Division, Abbott Healthcare Products B.V, Weesp, The Netherlands.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1-10. Date of Electronic Publication: 2021 May 06.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Influenza Vaccines*/adverse effects
Influenza, Human*/prevention & control
Adult ; Aged ; Antibodies, Viral ; Double-Blind Method ; Hemagglutination Inhibition Tests ; Humans ; Immunogenicity, Vaccine ; India ; Vaccines, Combined ; Vaccines, Inactivated/adverse effects
Czasopismo naukowe
Tytuł:
Factors influencing healthcare professionals' confidence in vaccination in Europe: a literature review.
Autorzy:
Pavlovic D; School of Medicine, University of Zagreb, Zagreb, Croatia.
Sahoo P; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Larson HJ; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Zagreb, Croatia.
Karafillakis E; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Zagreb, Croatia.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 2041360. Date of Electronic Publication: 2022 Mar 15.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Health Knowledge, Attitudes, Practice*
Influenza Vaccines*
Europe ; Health Personnel ; Humans ; Vaccination
Czasopismo naukowe
Tytuł:
Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study.
Autorzy:
Fan R; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, China.
Huang X; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, China.
Nian X; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, China.
Ou Z; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, China.
Zhou J; Gaozhou Center for Disease Control and Prevention, Gaozhou, China.
Zhang J; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, China.
Zeng P; Gaozhou Center for Disease Control and Prevention, Gaozhou, China.
Zhao W; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, China.
Deng J; Gaozhou Center for Disease Control and Prevention, Gaozhou, China.
Chen W; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, China.
Chen S; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, China.
Duan K; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, China.
Chen Y; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, China.
Li X; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, China.
Zhang J; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, China.
Yang X; National Engineering Technology Research Center of Combined Vaccines, Wuhan, China.; China National Biotec Group Company Limited, Beijing, China.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1-9. Date of Electronic Publication: 2021 Sep 02.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms:
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Influenza, Human*/prevention & control
Adult ; Aged ; Antibodies, Viral ; Hemagglutination Inhibition Tests ; Humans ; Immunogenicity, Vaccine ; Influenza A Virus, H3N2 Subtype ; Vaccines, Combined ; Vaccines, Inactivated
Czasopismo naukowe
Tytuł:
Influenza vaccination uptake and its determinants during the 2019-2020 and early 2020-2021 flu seasons among migrants in Shanghai, China: a cross-sectional survey.
Autorzy:
Han K; School of Public Health, Fudan University, Shanghai, China.; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Francis MR; Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.
Xia A; School of Public Health, Fudan University, Shanghai, China.
Zhang R; School of Public Health, Fudan University, Shanghai, China.
Hou Z; School of Public Health, Fudan University, Shanghai, China.; NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1-8. Date of Electronic Publication: 2022 Jan 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Transients and Migrants*
China/epidemiology ; Cross-Sectional Studies ; Humans ; Pandemics/prevention & control ; Seasons ; Vaccination
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz